Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.cipla.com | |
Market Cap | 120,838.63 Cr. | |
Enterprise Value(EV) | 117,870.04 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 45.93 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 32.59 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.15 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 320.72 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 4.67 | Calculated using Price: 1,499.05 |
Dividend Yield | 0.57 | Period Ending 2023-03 |
No. of Shares Subscribed | 80.74 Cr. | 807,367,062 Shares |
FaceValue | 2 | |
About Cipla Ltd. | ||
The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The company has its wide network of manufacturing, trading and other incidental operations in India and International markets. |
1 Day |
|
+2.30% |
1 Week |
|
+5.61% |
1 Month |
|
+0.64% |
3 Month |
|
+20.75% |
6 Month |
|
+26.81% |
1 Year |
|
+68.33% |
2 Year |
|
+47.70% |
5 Year |
|
+184.86% |
10 Year |
|
+287.41% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 12.1 | 12.61 | 8.72 | 10.65 | 10.37 | 10.09 | 14.13 | 13.1 | 12.85 | |
Return on Capital Employed (%) | 15.33 | 13.24 | 8.28 | 10.2 | 11.94 | 12.53 | 17.85 | 17.24 | 18.19 | |
Return on Assets (%) | 7.85 | 7.28 | 4.97 | 6.52 | 6.5 | 6.56 | 9.95 | 9.94 | 10.19 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 10,801 | 11,516 | 12,544 | 14,229 | 15,012 | 15,763 | 18,327 | 20,842 | 23,408 | 24,825 | |
Non Curr. Liab. | 2,418 | 1,407 | 4,513 | 4,259 | 4,646 | 2,972 | 1,660 | 622 | 184 | 146 | |
Curr. Liab. | 3,881 | 7,776 | 3,374 | 3,832 | 3,772 | 4,393 | 4,591 | 4,913 | 5,033 | 5,648 | |
Minority Int. | 180 | 350 | 438 | 352 | 332 | 294 | 259 | 276 | 306 | 270 | |
Equity & Liab. | 17,281 | 21,049 | 20,869 | 22,673 | 23,762 | 23,423 | 24,837 | 26,652 | 29,007 | 30,889 | |
Non Curr. Assets | 9,689 | 12,208 | 12,064 | 11,859 | 11,335 | 11,717 | 11,628 | 11,925 | 11,732 | 11,882 | |
Curr. Assets | 7,591 | 8,841 | 8,736 | 10,814 | 12,425 | 11,704 | 13,181 | 14,711 | 16,805 | 19,007 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 17,281 | 21,049 | 20,869 | 22,673 | 23,762 | 23,423 | 24,837 | 26,652 | 29,007 | 30,889 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 11,345 | 13,595 | 14,394 | 15,156 | 16,362 | 17,132 | 19,160 | 21,763 | 22,753 | 25,350 | |
Other Income | 166 | 208 | 229 | 358 | 477 | 369 | 270 | 322 | 512 | 632 | |
Total Income | 11,511 | 13,803 | 14,623 | 15,513 | 16,839 | 17,501 | 19,429 | 22,085 | 23,265 | 25,982 | |
Total Expenditure | -9,184 | -11,115 | -11,919 | -12,329 | -13,265 | -13,951 | -14,911 | -17,251 | -17,763 | -19,201 | |
PBIDT | 2,327 | 2,688 | 2,704 | 3,184 | 3,574 | 3,550 | 4,518 | 4,834 | 5,502 | 6,781 | |
Interest | -168 | -207 | -159 | -114 | -168 | -197 | -161 | -106 | -110 | -107 | |
Depreciation | -505 | -754 | -1,323 | -1,323 | -1,326 | -1,175 | -1,068 | -1,052 | -1,172 | -1,109 | |
Taxation | -400 | -332 | -180 | -250 | -570 | -631 | -889 | -934 | -1,203 | -1,444 | |
Exceptional Items | -78 | -182 | -182 | -377 | |||||||
PAT | 1,254 | 1,395 | 1,042 | 1,419 | 1,510 | 1,547 | 2,401 | 2,559 | 2,835 | 3,744 | |
Minority Interest | -48 | -23 | -29 | -6 | 35 | 47 | 16 | -30 | -31 | -35 | |
Share Associate | -25 | -12 | -7 | -3 | -17 | -47 | -13 | -13 | -3 | -1 | |
Other Related Items | |||||||||||
Consolidated Net Profit | 1,181 | 1,360 | 1,006 | 1,411 | 1,528 | 1,547 | 2,405 | 2,517 | 2,802 | 3,708 | |
Adjusted EPS | 15 | 17 | 13 | 18 | 19 | 19 | 30 | 31 | 35 | 46 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 1,563 | 1,173 | 1,741 | 2,382 | 1,463 | 1,691 | 3,068 | 3,755 | 3,326 | 3,238 | |
Cash Fr. Inv. | -1,250 | -941 | -4,523 | -1,310 | -854 | -1,669 | 104 | -2,387 | -1,872 | -2,389 | |
Cash Fr. Finan. | -266 | 165 | 3,104 | -1,326 | -385 | -349 | -2,949 | -1,240 | -1,600 | -958 | |
Net Change | 48 | 397 | 322 | -254 | 223 | -326 | 224 | 129 | -146 | -109 | |
Cash & Cash Eqvt | 176 | 564 | 858 | 610 | 853 | 508 | 742 | 790 | 658 | 561 |
Wed, 27 Mar 2024
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent CIPLA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
Wed, 27 Mar 2024
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent CIPLA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
Wed, 27 Mar 2024
Amalgamation OR Merger-XBRL CIPLA LIMITED has informed the Exchange regarding Amalgamation/ Merger |
Wed, 27 Mar 2024 |
Close Within 52 Week High Zone |
High Increase in 3 Months |
High Increase in 6 Months |
High Increase in 1 Year |
High Increase in 5 Years |